HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes.

Abstract
Vasculopathy is a major complication of diabetes; however, molecular mechanisms mediating the development of vasculopathy and potential strategies for prevention have not been identified. We have previously reported that C-peptide prevents diabetic vasculopathy by inhibiting reactive oxygen species (ROS)-mediated endothelial apoptosis. To gain further insight into ROS-dependent mechanism of diabetic vasculopathy and its prevention, we studied high glucose-induced cytosolic and mitochondrial ROS production and its effect on altered mitochondrial dynamics and apoptosis. For the therapeutic strategy, we investigated the vasoprotective mechanism of C-peptide against hyperglycemia-induced endothelial damage through the AMP-activated protein kinase α (AMPKα) pathway using human umbilical vein endothelial cells and aorta of diabetic mice. High glucose (33 mmol/L) increased intracellular ROS through a mechanism involving interregulation between cytosolic and mitochondrial ROS generation. C-peptide (1 nmol/L) activation of AMPKα inhibited high glucose-induced ROS generation, mitochondrial fission, mitochondrial membrane potential collapse, and endothelial cell apoptosis. Additionally, the AMPK activator 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside and the antihyperglycemic drug metformin mimicked protective effects of C-peptide. C-peptide replacement therapy normalized hyperglycemia-induced AMPKα dephosphorylation, ROS generation, and mitochondrial disorganization in aorta of diabetic mice. These findings highlight a novel mechanism by which C-peptide activates AMPKα and protects against hyperglycemia-induced vasculopathy.
AuthorsMahendra Prasad Bhatt, Young-Cheol Lim, Young-Myeong Kim, Kwon-Soo Ha
JournalDiabetes (Diabetes) Vol. 62 Issue 11 Pg. 3851-62 (Nov 2013) ISSN: 1939-327X [Electronic] United States
PMID23884890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • C-Peptide
  • Reactive Oxygen Species
  • Aminoimidazole Carboxamide
  • Metformin
  • AMP-Activated Protein Kinases
  • Glucose
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Aminoimidazole Carboxamide (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • C-Peptide (pharmacology, therapeutic use)
  • Cells, Cultured
  • Cytosol (metabolism)
  • Diabetes Mellitus, Experimental (drug therapy)
  • Diabetic Angiopathies (etiology)
  • Enzyme Activation
  • Glucose (administration & dosage, pharmacology)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Male
  • Membrane Potential, Mitochondrial (drug effects)
  • Metformin (pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Mitochondrial Dynamics (drug effects)
  • Reactive Oxygen Species (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: